v3.25.4
Income Tax (Tables)
12 Months Ended
Dec. 31, 2025
Income Tax [Abstract]  
Schedule of Deferred Tax Assets

Significant components of the Company’s deferred tax assets are as follows:

 

    As of December 31,   
    2025     2024 
Deferred tax assets:        
Net operating losses  $8,696,586   $6,356,812 
Tax credits   1,005,896    812,541 
Intangible assets   47,562    52,813 
Capitalized R&D expenses   2,140,990    2,619,730 
Fixed assets   9,246    
-
 
Other   189,326    193,197 
Total deferred tax assets   12,089,606    10,035,093 
Valuation allowance   (12,089,606)   (10,035,093)
Deferred tax asset, net of allowance  $
-
   $
-
 
Schedule of Effective Tax Rate

A reconciliation of the statutory tax rates and the effective tax rates for the years ended December 2025 and 2024 is as follows:

 

   Year Ended December 31, 
   2025   2024 
Federal statutory rate   21.00%   21.00%
Research tax credits   2.22%   2.43%
Nontaxable and nondeductible items   (0.05)%   (0.08)%
Other   (0.02)%   (0.20)%
Change in valuation allowance   (23.15)%   (23.16)%
Effective tax rate   0.00%   0.00%